Hori­zon takes the leap in­to man­u­fac­tur­ing, buy­ing out an Irish plant with around 40 em­ploy­ees in tow

Hori­zon Ther­a­peu­tics, the biotech known for scoop­ing up or­phan drugs, has made its first for­ay in­to man­u­fac­tur­ing with the pur­chase of a fa­cil­i­ty in Wa­ter­ford, Ire­land.

Eir­Gen Phar­ma has sold its site to Hori­zon for $65 mil­lion and will trans­fer 40 em­ploy­ees to the com­pa­ny. The site is lo­cat­ed in an In­dus­tri­al De­vel­op­ment Agency Ire­land busi­ness park and will in­clude a fill­ing line and a freeze dry­er that can be used for Hori­zon’s com­mer­cial med­i­cines Te­pez­za, Up­liz­na and Krys­texxa. It will al­so be used for drug de­vel­op­ment, the com­pa­ny said in a re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER